46 related articles for article (PubMed ID: 8789491)
1. Current trends in the features of male thyroid cancer: Retrospective evaluation of their prognostic value.
Kim MJ; Lee SG; Kim K; Lee CR; Kang SW; Lee J; Nam KH; Chung WY; Jeong JJ
Medicine (Baltimore); 2019 May; 98(19):e15559. PubMed ID: 31083219
[TBL] [Abstract][Full Text] [Related]
2. Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes.
Kim SY; Kim BW; Pyo JY; Hong SW; Chang HS; Park CS
World J Surg; 2018 Jan; 42(1):123-129. PubMed ID: 28779384
[TBL] [Abstract][Full Text] [Related]
3. Pathologic reporting of lymph node metastases in differentiated thyroid cancer: a call to action for the College of American Pathologists.
Urken ML; Mechanick JI; Sarlin J; Scherl S; Wenig BM
Endocr Pathol; 2014 Sep; 25(3):214-8. PubMed ID: 24292975
[TBL] [Abstract][Full Text] [Related]
4. Is thymectomy worthwhile in central lymph node dissection for differentiated thyroid cancer?
El Khatib Z; Lamblin J; Aubert S; Arnalsteen L; Leteurtre E; Caiazzo R; Pattou F; Carnaille B
World J Surg; 2010 Jun; 34(6):1181-6. PubMed ID: 20094884
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis.
Backus J; Laughlin T; Wang Y; Belly R; White R; Baden J; Justus Min C; Mannie A; Tafra L; Atkins D; Verbanac KM
J Mol Diagn; 2005 Aug; 7(3):327-36. PubMed ID: 16049304
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
7. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
Schlag PM
Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
[TBL] [Abstract][Full Text] [Related]
8. Pathologic examination of sentinel lymph nodes in breast cancer.
Ku NN
Surg Oncol Clin N Am; 1999 Jul; 8(3):469-79. PubMed ID: 10448690
[TBL] [Abstract][Full Text] [Related]
9. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study for detecting micrometastases of lymph nodes in patients with lung cancer].
Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Tong XY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):19-21. PubMed ID: 18346373
[TBL] [Abstract][Full Text] [Related]
12. Surgical pathology of lymph nodes in cancer staging: routine and specialized techniques.
Siegel RJ
Surg Oncol Clin N Am; 1996 Jan; 5(1):25-31. PubMed ID: 8789491
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK
Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
